Pharmafile Logo

OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward

October 20, 2020 |  

The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either been cancelled or re-organised to be virtual in a short space of time. We fully expect that this isn’t in the short term and reflects the future to come. These changes were unprecedented but reshaping the way we carry out activities has unveiled a new strength and opportunity to add value through a multi channel approach.

OPEN Health, much like the rest of the industry quickly adapted our activities at the start of COVID-19. We’re extremely proud of all our teams for delivering clinically relevant, fresh and purposeful virtual solutions for all our clients. Over the last few months, our teams have worked incredibly hard to deliver over 250 fantastic virtual projects for our clients. See below an indication of some of the activities we’ve worked on:

Pink divider
- PMLiVE

As we head towards the end of the year, we will be looking back and reflecting at our virtual activities from 2020, gathering feedback from clients and HCPs on the most impactful activities and will be providing our recommendations for 2021. Keep an eye out for future blogs, webinars and more covering these topics.

Pink divider

To learn more about our virtual capabilities, please contact:

Louise Carrington, Client Partnerships Director

Email: LouiseCarrington@openhealthgroup.com

Mobile: +44 (0)7468 714548

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

Spotlight interview: 15 minutes on digital in medical communications

Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications

Generating data on long-term outcomes with gene and other advanced therapies

Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’.

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Spotlight interview: 15 minutes on insights and market research in pharma

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...

Patient journey mapping: exploring the clinical and the emotional journey

By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...

OPEN Health announces the integration of Pharmerit International into the group

OPEN Health has today announced the integration of Pharmerit International, a global leader in health economics and outcomes research (HEOR), into its group of companies.

OPEN Health mobilised to support outcomes with gene and other advanced therapies

Harnessing the power of collaborations to bring real insights and improve outcomes

Spotlight interview: 15 minutes on PR in pharma

Vicky Bramham, Managing Director, OPEN Health takes 15 minutes to answer some key questions on PR discipline.

OPEN Health PBC recognised as No. 1 independent creative agency

We’re No.1! PMLive have named OPEN Health Patient & Brand Communications as the no.1 independent creative healthcare agency. The aim of the PMLive Top 10 lists is to highlight those...